BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37326897)

  • 1. GABRP Promotes the Metastasis of Pancreatic Cancer by Activation of the MEK/ERK Signaling Pathway.
    Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
    Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer.
    Sung HY; Yang SD; Ju W; Ahn JH
    Exp Mol Med; 2017 May; 49(5):e335. PubMed ID: 28524180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
    Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
    Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
    Yu X; Huang M; Yang G
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway.
    Li F; Wang J; Yan YQ; Bai CZ; Guo JQ
    BMC Cancer; 2023 Dec; 23(1):1214. PubMed ID: 38066486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca
    Jiang SH; Zhu LL; Zhang M; Li RK; Yang Q; Yan JY; Zhang C; Yang JY; Dong FY; Dai M; Hu LP; Li J; Li Q; Wang YH; Yang XM; Zhang YL; Nie HZ; Zhu L; Zhang XL; Tian GA; Zhang XX; Cao XY; Tao LY; Huang S; Jiang YS; Hua R; Qian Luo K; Gu JR; Sun YW; Hou S; Zhang ZG
    Gut; 2019 Nov; 68(11):1994-2006. PubMed ID: 30826748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway.
    Hou CH; Lin FL; Hou SM; Liu JF
    Mol Cancer; 2014 Oct; 13():236. PubMed ID: 25326651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-canonical Small GTPase RBJ Promotes NSCLC Progression Through the Canonical MEK/ERK Signaling Pathway.
    Wang Y; Shen X; Wang Q; Guo Z; Hu L; Dong Z; Hu W
    Curr Pharm Des; 2022; 28(42):3446-3455. PubMed ID: 36397632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
    Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
    Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancreatic cancer.
    Liu Y; Qin P; Wu R; Du L; Li F
    Hum Cell; 2020 Oct; 33(4):1186-1196. PubMed ID: 32700262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
    Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer.
    Chen C; Wu B; Wang M; Chen J; Huang Z; Shi JS
    PeerJ; 2022; 10():e12728. PubMed ID: 35846884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway.
    Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
    Biochem Biophys Res Commun; 2022 Sep; 619():76-83. PubMed ID: 35749939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/ERK signaling pathway.
    Weng K; Li L; Zhou H
    Histol Histopathol; 2023 Dec; 38(12):1381-1390. PubMed ID: 36537752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
    Liu X; Sun L; Zhang S; Zhang S; Li W
    J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 promotes migration and invasion of cholangiocarcinoma arising from choledochal cyst by transcriptionally inhibiting miR200c through the c-myb/MEK/ERK signaling pathway.
    Liu W; Fan L; Shao B; Zhang Y
    Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):136-142. PubMed ID: 37807322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEIL3 promotes hepatoma epithelial-mesenchymal transition by activating the BRAF/MEK/ERK/TWIST signaling pathway.
    Lai HH; Hung LY; Yen CJ; Hung HC; Chen RY; Ku YC; Lo HT; Tsai HW; Lee YP; Yang TH; Chen YY; Huang YS; Huang W
    J Pathol; 2022 Dec; 258(4):339-352. PubMed ID: 36181299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.